Teva Gains ANDA Approval For Generic Actonel
This article was originally published in The Pink Sheet Daily
Firm awaits Delaware federal court decision on pending litigation with Actonel marketer Procter & Gamble.
You may also be interested in...
Recent journal articles on the osteoporosis products’ association with atrial fibrillation spark an “early safety communication" from the agency.
Adiana uses a polymer matrix insert to block the fallopian tubes instead of a metal coil, offering a benefit over Essure, which carries a perforation risk on implantation, Hologic exec says.
The results show that cardiac resynchronization defibrillators "slow the progression of heart failure in asymptomatic and mildly symptomatic patients," potentially expanding the market by $600 million.